Oragen

From Wikipedia, the free encyclopedia

Oragen drugs are highly experimental nucleic acid technologies related to Ampligen, developed by HEMISPHERx Biopharma, Inc. It is hoped they will have antiviral effects. They are undergoing pre-clinial (in-vitro) trials.

[edit] Mechanism Of Action

It is believed that Oragen regulates the RNase L pathway and may also have effects specifically against the HIV virus.

[edit] External links

• Hemispherx Oragen Page